Viewing 4 reply threads
  • Author
    Posts
    • #19379
      Steve Lester
      Participant

      Lately I’ve been exchanging emails and phone calls with Dan Montano, CEO of Zhittya Genesis Medicine, Inc. Googled information on him is all over the map. I’m considering investing in this miracle drug his company offers which he seems to truly believe will cure PD following the results of animal studies. Human studies should begin in a few months, he says. If you know anything about him or his company, I’m all ears.

    • #19389
      Steve Lester
      Participant

      Today I spoke with a trusted financial advisor who used his resources to research Mr. Montano and his company. He mentioned a “shady past” in Mr. Montano’s background. In terms of investing any money in his company, Zhittya Genesis Medicine, Inc. he said, “If it were me I’d run away, and run away fast.”

    • #19975
      Christina
      Participant

      Hi Steve, Although this turned out to be a dead end, I really appreciate your leaving no stone unturned and willingness to seek out new possibilities.

       

    • #20605
      Dan Montano
      Participant

      Zhittya Genesis Medicine announced in its April Update that it has a regulatory pathway to start its Phase I, Proof of Concept clinical trial to utilize FGF-1 to treat Parkinson’s Disease. Dan Montano CEO of Zhittya Genesis Medicine stated that he hopes by the end of 2020 to have human clinical data if the infusion of FGF-1 into humans is safe and has any benefits for Parkinson’s suffers.

    • #21686
      Lee
      Participant

      Any news from Mexico how the trial is going ?

Viewing 4 reply threads
  • You must be logged in to reply to this topic.

©2022 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

or    

Forgot your details?

Create Account